Mobile

Clinical and pharmacokinetic phase II study of one hour infusion of kahalalide F administered every week to patients with Non Small Cell Lung Cancer Stage IIIB with pleural effusion and stage IV, afte...

Update Il y a 4 ans
Reference: EUCTR2004-001253-29

Clinical and pharmacokinetic phase II study of one hour infusion of kahalalide F administered every week to patients with Non Small Cell Lung Cancer Stage IIIB with pleural effusion and stage IV, after first line chemotherapy

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

Evaluar la actividad antitumoral de Kahalalide administrado en infusion semanal de una hora a pacientes con cancer de pulmon no microcitico, estadio IIIB con derrame pleural y estado IV , tras una primera linea de quimioterapia.

Inclusion criteria

  • Non Small Cell Lung Cancer Stage IIIB and IV after first Line Chemotherapy

Links